LEVOsimendan before Heart-Lung-Machine in coronary artery bypass graft operations.

Trial Profile

LEVOsimendan before Heart-Lung-Machine in coronary artery bypass graft operations.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2014

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms LEVOHLM
  • Most Recent Events

    • 29 Apr 2014 Primary endpoint 'Sequential-Organ-Failure-Assessment' has not been met.
    • 29 Apr 2014 Results published in the Journal of International Medical Research.
    • 01 Jun 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2007-004674-49).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top